Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph early_phase_1
2
50%
Ph phase_2
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (50.0%)
Phase 21 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

NCT03576768
completedphase_2

10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence

NCT03238859
completedearly_phase_1

Developing rTMS Treatment Strategies for Pain in Opiate Dependence

NCT03576781
completedearly_phase_1

Nicotine TMS EFT Smoking Pilot Study

NCT03579953

Clinical Trials (4)

Showing 4 of 4 trials
NCT03576768Not Applicable

QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

Terminated
NCT03238859Phase 2

10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence

Completed
NCT03576781Early Phase 1

Developing rTMS Treatment Strategies for Pain in Opiate Dependence

Completed
NCT03579953Early Phase 1

Nicotine TMS EFT Smoking Pilot Study

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4